Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 5Thoracic 3Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 30Small Cell Lung Carcinoma 13Recurrence 3Melanoma 3Lung Neoplasms 3Advanced Lung Cancer 3NSCLC 2Lymphoma 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Treatment-naive Advanced Non-small Cell Lung Cancer 1Thoracic Neoplasms 1Stage IB-IIIB NSCLC 1Small Cell Lung Cancer Limited Stage 1Sarcoma 1SCLC, Extensive Stage 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Ovarian Neoplasms 1Non-small Lung Cancer 1Non Squamous Non Small Cell Lung Cancer 1Non Small Cell Lung Cancer Recurrent 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Lung Diseases 1Local Advanced Non-small Cell Lung Cancer 1Liver Neoplasms 1Kidney Neoplasms 1

Interventions

Docetaxel 8pembrolizumab 7Pemetrexed 5Carboplatin 5Erlotinib Hydrochloride 4toripalimab 3rociletinib 3fludarabine 3Radiosurgery 3Paclitaxel 3Oxaliplatin 3Nivolumab 3Gemcitabine 3Etoposide 3Cyclophosphamide 3Cisplatin 3Bevacizumab 3lorlatinib 2atezolizumab 2Vinorelbine 2Topotecan 2Radiotherapy 2Platinum 2Itraconazole 2Irinotecan 2Interleukin-2 2Cetuximab 2Albumin-Bound Paclitaxel 2vinflunine 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recurrence × toripalimab × Thoracic × Clear all
NCT07097948 2025-08-01

Adjuvant

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
40 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
100 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT04797702 2021-03-15

CT32

Shanghai Junshi Bioscience Co., Ltd.

Phase 1/2 Unknown
67 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡